#elililly

  • Weekly Giveaway for our active users. N50,000 per Week. Do you want to contribute to this community? We are looking for contribution? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing Nigerian forum!
  1. A

    Eli Lilly Expands Access to Zepbound with Affordable Single-Dose Vials for Obesity Treatment

    Eli Lilly and Company (NYSE: LLY) has launched Zepbound® (tirzepatide) single-dose vials, available through its LillyDirect® self-pay channel, significantly expanding access to obesity treatment. These vials are priced at least 50% lower than other incretin (GLP-1) medicines for obesity...